Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 45, 2011 - Issue 5
Submit an article Journal homepage
135
Views
2
CrossRef citations to date
0
Altmetric
Urology

Does the outcome of prostate cancer patients with large prostates differ from small prostate size in permanent seed, low dose-rate brachytherapy?

Sirpa H. AaltomaaDepartment of Urology, Kuopio University Hospital, Kuopio, FinlandCorrespondence[email protected]
,
Vesa V. KatajaDepartment of Oncology, Cancer Center, Kuopio University Hospital, Vaasa, Finland;Department of Physics, Kuopio University Hospital, Kuopio, Finland
,
Atte RätyDepartment of Urology, Kuopio University Hospital, Kuopio, Finland
,
Jan-Erik PalmgrenDepartment of Oncology, Cancer Center, Kuopio University Hospital, Vaasa, Finland
&
Tapani LahtinenDepartment of Oncology, Cancer Center, Kuopio University Hospital, Vaasa, Finland
Pages 339-345 | Received 21 Jan 2011, Accepted 06 May 2011, Published online: 19 Jul 2011

References

  • Pickles T, Morris WJ, Kattan MW, Keyes M. Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer. Brachytherapy 2011;10:9–14.
  • Norderhaug I, Dahl O, Hoisaeter PA, Heikkila R, Klepp O, Olsen DR, Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness. Eur Urol 2003;44:40–6.
  • Giberti C, Chiono L, Gallo F, Schenone M, Gastaldi E. Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study. World J Urol 2009;27:607–12.
  • Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L, ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000;57:315–21.
  • Mabjeesh NJ, Chen J, Stenger A, Matzkin H. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy. Urology 2007;70:548–53.
  • Acher PL, Popert R, Morris SL, Potters L, Austin-Smith SL, Johnson UH, Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation. BJU Int 2007;99:1066–71.
  • Lehrer S, Stone NN, Stock RG. Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy. J Urol 2005;173:79–81.
  • Koutrouvelis PG, Lailas N, Katz S, Sehn J, Gil-Montero G, Khawand N. Prostate cancer with large glands treated with 3-dimensional computerized tomography guided pararectal brachytherapy: up to 8 years of followup. J Urol 2003;169:1331–6.
  • Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup. Brachytherapy 2006;5:122–6.
  • Sylvester JE, Grimm PD, Wong J, Galbreath RW, Merrick G, Blasko JC. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys 2010. doi:10.1016/j.ijrobp.2010.05.042
  • Cosset JM, Flam T, Thiounn N, Gomme S, Rosenwald JC, Asselain B, Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital Group on 809 patients. Int J Radiat Oncol Biol Phys 2008;71:1042–8.
  • Kanai K, Nakashima J, Sugawara A, Shigematsu N, Nagata H, Kikuchi E, Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer. Int J Clin Oncol 2009;14:502–6.
  • Mitchell DM, Swindell R, Elliott T, Wylie JP, Taylor CM, Logue JP. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer. Radiother Oncol 2008;88:102–7.
  • Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Int J Radiat Oncol Biol Phys 2006;64:512–17.
  • Nobes JP, Wells IG, Khaksar SJ, Money-Kyrle JF, Laing RW, Langley SE. Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience. Prostate Cancer Prostatic Dis 2009;12:61–6.
  • Hinnen KA, Battermann JJ, van Roermund JG, Moerland MA, Jurgenliemk-Schulz IM, Frank SJ, Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2010;76:1433–8.
  • Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE. Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapy. Brachytherapy 2010;9:42–9.
  • Beyer DC, McKeough T, Thomas T. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005;61:1299–305.
  • Battermann JJ, Boon TA, Moerland MA. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 2004;71:23–8.
  • Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 2007;67:327–33.
  • Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 2001;51:31–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.